CRISPR Therapeutics AG (CRSP) Social Stream



CRISPR Therapeutics AG (CRSP): $119.61

1.80 (+1.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRSP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

CRISPR Therapeutics AG (CRSP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRSP.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
18 $220 $117 $162.94 $117.26 38.96%

The Trend in the Analyst Price Target


CRSP's average price target has moved up $67.73 over the prior 13 months.

CRSP reports an average of 10.54% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-18 18 220 117 162.94 119.32 36.56%
2021-07-02 18 220 117 163.11 155.88 4.64%
2021-06-01 18 220 55 158.78 115.80 37.12%
2021-04-19 17 210 45 157.12 115.04 36.58%
2021-04-17 17 210 45 157.12 118.56 32.52%
2021-03-17 16 210 45 157.56 131.10 20.18%
2021-03-13 16 210 45 157.56 130.61 20.63%
2021-01-25 16 210 45 146.56 181.24 -19.13%
2021-01-23 16 210 45 146.56 188.49 -22.25%
2021-01-16 16 210 45 146.56 199.88 -26.68%
2020-11-26 16 140 45 102.63 110.00 -6.7%
2020-11-11 16 140 45 102.62 100.64 1.97%
2020-10-28 16 140 47 102.75 94.71 8.49%
2020-10-04 13 140 31 98.54 79.67 23.69%
2020-09-01 14 140 31 95.21 NA NA%
2020-07-28 14 140 31 95.21 NA NA%
2020-07-13 14 140 31 81.75 NA NA%
2020-06-22 13 105 31 77.27 NA NA%
2020-06-22 14 105 31 75.75 NA NA%
2020-06-18 14 105 31 74.46 NA NA%
2020-06-09 14 104 31 73.82 NA NA%

CRSP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.55 6 8 6 0 0 21

The Trend in the Broker Recommendations


CRSP's average broker recommendation rating improved by 0.09 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The average analyst price target of CRSP is higher than 91.46% of all US stocks.
  • CRSP has a higher number of analysts covering the stock than 95.66% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of CRSP is higher than 88.73% of stocks in the large market cap category.
  • CRSP has a less variance in analysts' estimates than 15.6% of all US stocks.

In the Pharmaceutical Products industry, JNJ, SRPT and SGEN are the three stocks most similar to CRISPR Therapeutics AG regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CRSP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7615 seconds.